Rhode Island SB 136: AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- PRESCRIPTION DRUG SALES -- REPRESENTATIVE DISCLOSURE ACT (Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative and to pay an annual fee for each name listed with the department of business regulation.)

Status: 03/28/2019 Committee recommended measure be held for further study (as of 2019-03-28)

State: Rhode Island · Session: 2019 · Bill: SB 136

Subjects: Business & Professions, Fees

Sponsors: Goldin, Miller, Satchell, Sosnowski, Valverde

View Rhode Island SB 136 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.